235 related articles for article (PubMed ID: 26663780)
21. Kinetics of interferon-gamma producing cytomegalovirus (CMV)-specific CD4+ and CD8+ T lymphocytes and the risk of subsequent CMV viremia after allogeneic hematopoietic stem cell transplantation.
Eid AJ; Brown RA; Hogan WJ; Lahr BD; Eckel-Passow JE; Litzow MR; Razonable RR
Transpl Infect Dis; 2009 Dec; 11(6):519-28. PubMed ID: 19744286
[TBL] [Abstract][Full Text] [Related]
22. Human Cytomegalovirus (HCMV)-Specific CD4
Jackson SE; Sedikides GX; Mason GM; Okecha G; Wills MR
J Virol; 2017 Mar; 91(6):. PubMed ID: 28053099
[TBL] [Abstract][Full Text] [Related]
23. B and T lymphocyte attenuator is highly expressed on CMV-specific T cells during infection and regulates their function.
Serriari NE; Gondois-Rey F; Guillaume Y; Remmerswaal EB; Pastor S; Messal N; Truneh A; Hirsch I; van Lier RA; Olive D
J Immunol; 2010 Sep; 185(6):3140-8. PubMed ID: 20693422
[TBL] [Abstract][Full Text] [Related]
24. Polyfunctional T-Cell Signatures to Predict Protection from Cytomegalovirus after Lung Transplantation.
Snyder LD; Chan C; Kwon D; Yi JS; Martissa JA; Copeland CA; Osborne RJ; Sparks SD; Palmer SM; Weinhold KJ
Am J Respir Crit Care Med; 2016 Jan; 193(1):78-85. PubMed ID: 26372850
[TBL] [Abstract][Full Text] [Related]
25. Properties of CD4(+) T cells in human cytomegalovirus infection.
Gamadia LE; Rentenaar RJ; van Lier RA; ten Berge IJ
Hum Immunol; 2004 May; 65(5):486-92. PubMed ID: 15172448
[TBL] [Abstract][Full Text] [Related]
26. CMV exposure drives long-term CD57+ CD4 memory T-cell inflation following allogeneic stem cell transplant.
Yeh AC; Varelias A; Reddy A; Barone SM; Olver SD; Chilson K; Onstad LE; Ensbey KS; Henden AS; Samson L; Jaeger CA; Bi T; Dahlman KB; Kim TK; Zhang P; Degli-Esposti MA; Newell EW; Jagasia MH; Irish JM; Lee SJ; Hill GR
Blood; 2021 Dec; 138(26):2874-2885. PubMed ID: 34115118
[TBL] [Abstract][Full Text] [Related]
27. In vitro expansion of polyclonal T-cell subsets for adoptive immunotherapy by recombinant modified vaccinia Ankara.
La Rosa C; Wang Z; Lacey SF; Lalimarmo MM; Krishnan A; Longmate J; Diamond DJ
Exp Hematol; 2006 Apr; 34(4):497-507. PubMed ID: 16569596
[TBL] [Abstract][Full Text] [Related]
28. Kinetics of cytomegalovirus (CMV) pp65 and IE-1-specific IFNgamma CD8+ and CD4+ T cells during episodes of viral DNAemia in allogeneic stem cell transplant recipients: potential implications for the management of active CMV infection.
Tormo N; Solano C; Benet I; Nieto J; de la Cámara R; Garcia-Noblejas A; Clari MA; Chilet M; López J; Hernández-Boluda JC; Remigia MJ; Navarro D
J Med Virol; 2010 Jul; 82(7):1208-15. PubMed ID: 20513086
[TBL] [Abstract][Full Text] [Related]
29. Adoptive transfer of cytomegalovirus-specific effector CD4+ T cells provides antiviral protection from murine CMV infection.
Jeitziner SM; Walton SM; Torti N; Oxenius A
Eur J Immunol; 2013 Nov; 43(11):2886-95. PubMed ID: 23921569
[TBL] [Abstract][Full Text] [Related]
30. Induction of CMV-specific T-cell lines using Ag-presenting cells pulsed with CMV protein or peptide.
Einsele H; Rauser G; Grigoleit U; Hebart H; Sinzger C; Riegler S; Jahn G
Cytotherapy; 2002; 4(1):49-54. PubMed ID: 11953041
[TBL] [Abstract][Full Text] [Related]
31. Monitoring cytomegalovirus IE-1 and pp65-specific CD4+ and CD8+ T-cell responses after allogeneic stem cell transplantation may identify patients at risk for recurrent CMV reactivations.
Gratama JW; Brooimans RA; van der Holt B; Sintnicolaas K; van Doornum G; Niesters HG; Löwenberg B; Cornelissen JJ
Cytometry B Clin Cytom; 2008 Jul; 74(4):211-20. PubMed ID: 18454493
[TBL] [Abstract][Full Text] [Related]
32. Dynamics of cytomegalovirus (CMV)-specific T cells in HIV-1-infected individuals progressing to AIDS with CMV end-organ disease.
Bronke C; Palmer NM; Jansen CA; Westerlaken GH; Polstra AM; Reiss P; Bakker M; Miedema F; Tesselaar K; van Baarle D
J Infect Dis; 2005 Mar; 191(6):873-80. PubMed ID: 15717261
[TBL] [Abstract][Full Text] [Related]
33. Impact of age and cytomegalovirus on CD8
Cantisán S; Páez-Vega A; Santos F; Rodríguez-Benot A; Aguado R; Rivero A; Montejo M; Torre-Cisneros J; Solana R;
Exp Gerontol; 2017 Sep; 95():98-106. PubMed ID: 28465043
[TBL] [Abstract][Full Text] [Related]
34. CMV antigen-specific CD4+ and CD8+ T cell IFNgamma expression and proliferation responses in healthy CMV-seropositive individuals.
Sinclair E; Black D; Epling CL; Carvidi A; Josefowicz SZ; Bredt BM; Jacobson MA
Viral Immunol; 2004; 17(3):445-54. PubMed ID: 15357911
[TBL] [Abstract][Full Text] [Related]
35. Direct measurement of CD4+ and CD8+ T-cell responses to CMV in HIV-1-infected subjects.
Komanduri KV; Donahoe SM; Moretto WJ; Schmidt DK; Gillespie G; Ogg GS; Roederer M; Nixon DF; McCune JM
Virology; 2001 Jan; 279(2):459-70. PubMed ID: 11162802
[TBL] [Abstract][Full Text] [Related]
36. Antigen-specific T cell responses induced by Towne cytomegalovirus (CMV) vaccine in CMV-seronegative vaccine recipients.
Jacobson MA; Sinclair E; Bredt B; Agrillo L; Black D; Epling CL; Carvidi A; Ho T; Bains R; Adler SP
J Clin Virol; 2006 Mar; 35(3):332-7. PubMed ID: 16387547
[TBL] [Abstract][Full Text] [Related]
37. Transfection of dendritic cells with in vitro-transcribed CMV RNA induces polyclonal CD8+- and CD4+-mediated CMV-specific T cell responses.
Heine A; Grünebach F; Holderried T; Appel S; Weck MM; Dörfel D; Sinzger C; Brossart P
Mol Ther; 2006 Feb; 13(2):280-8. PubMed ID: 16219490
[TBL] [Abstract][Full Text] [Related]
38. Primary immune responses to human CMV: a critical role for IFN-gamma-producing CD4+ T cells in protection against CMV disease.
Gamadia LE; Remmerswaal EB; Weel JF; Bemelman F; van Lier RA; Ten Berge IJ
Blood; 2003 Apr; 101(7):2686-92. PubMed ID: 12411292
[TBL] [Abstract][Full Text] [Related]
39. Augmentation of virus-specific immunity after hematopoietic stem cell transplantation by adoptive T-cell therapy.
Peggs KS; Mackinnon S
Hum Immunol; 2004 May; 65(5):550-7. PubMed ID: 15172456
[TBL] [Abstract][Full Text] [Related]
40. An in vitro model of T cell activation by autologous cytomegalovirus (CMV)-infected human adult endothelial cells: contribution of CMV-enhanced endothelial ICAM-1.
Waldman WJ; Knight DA; Huang EH
J Immunol; 1998 Apr; 160(7):3143-51. PubMed ID: 9531269
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
